IRIS
VIGNERI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.377
AS - Asia 4.804
EU - Europa 4.153
SA - Sud America 885
AF - Africa 593
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 7
AN - Antartide 1
Totale 19.828
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.056
SG - Singapore 2.324
IT - Italia 1.514
CN - Cina 1.364
BR - Brasile 777
IE - Irlanda 765
UA - Ucraina 573
IN - India 427
CI - Costa d'Avorio 377
DE - Germania 286
RU - Federazione Russa 272
CA - Canada 266
VN - Vietnam 208
KR - Corea 159
NL - Olanda 136
GB - Regno Unito 126
SN - Senegal 113
BE - Belgio 107
SE - Svezia 81
FI - Finlandia 70
AR - Argentina 47
BD - Bangladesh 46
JP - Giappone 46
PL - Polonia 45
MX - Messico 41
CZ - Repubblica Ceca 34
FR - Francia 33
ES - Italia 29
IR - Iran 27
HK - Hong Kong 26
UZ - Uzbekistan 26
BJ - Benin 24
IQ - Iraq 24
TR - Turchia 24
ZA - Sudafrica 23
CH - Svizzera 21
EC - Ecuador 20
NG - Nigeria 18
AE - Emirati Arabi Uniti 15
GR - Grecia 15
ID - Indonesia 15
AT - Austria 14
CO - Colombia 12
IL - Israele 12
LB - Libano 10
MA - Marocco 10
VE - Venezuela 9
KE - Kenya 8
PK - Pakistan 8
OM - Oman 7
SA - Arabia Saudita 7
AU - Australia 6
BG - Bulgaria 6
EG - Egitto 6
JO - Giordania 6
LT - Lituania 6
MY - Malesia 6
TN - Tunisia 6
AL - Albania 5
AZ - Azerbaigian 5
CL - Cile 5
PY - Paraguay 5
DO - Repubblica Dominicana 4
EU - Europa 4
RS - Serbia 4
BO - Bolivia 3
DZ - Algeria 3
KZ - Kazakistan 3
PE - Perù 3
RO - Romania 3
UY - Uruguay 3
CR - Costa Rica 2
GA - Gabon 2
JM - Giamaica 2
NI - Nicaragua 2
NO - Norvegia 2
NP - Nepal 2
PS - Palestinian Territory 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BW - Botswana 1
BY - Bielorussia 1
CM - Camerun 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
DM - Dominica 1
ET - Etiopia 1
GL - Groenlandia 1
HU - Ungheria 1
LV - Lettonia 1
NC - Nuova Caledonia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PT - Portogallo 1
SR - Suriname 1
TH - Thailandia 1
Totale 19.827
Salva come PNG Salva come JPEG
Città #
Dallas 1.826
Santa Clara 1.366
Singapore 1.262
Chandler 840
Dublin 764
Jacksonville 646
Chicago 526
Catania 417
Abidjan 377
Ashburn 345
Kochi 337
Hefei 335
Boardman 334
Cambridge 206
Lawrence 203
Nanjing 200
Los Angeles 198
Andover 193
Beijing 187
Toronto 161
Seoul 158
Grafing 134
Dakar 113
New York 112
Des Moines 111
San Mateo 100
Civitanova Marche 98
Moscow 95
Wilmington 86
Buffalo 81
Ho Chi Minh City 67
São Paulo 67
Munich 63
Milan 57
Rotterdam 56
Ottawa 54
Palermo 54
Nanchang 51
Rome 51
Wingene 50
Hebei 47
Hanoi 46
Tokyo 46
Shenyang 45
Dong Ket 40
Saint Petersburg 38
Council Bluffs 35
Bremen 34
Brussels 34
Seattle 34
Warsaw 34
Bari 33
Portland 33
The Dalles 32
Brooklyn 31
Changsha 30
Columbus 30
Jiaxing 30
Rio de Janeiro 29
Brno 28
Lappeenranta 28
Montreal 28
Chennai 27
Falls Church 26
Tianjin 26
Hong Kong 25
Turku 25
Cotonou 24
San Giovanni la Punta 23
Amsterdam 22
Atlanta 21
Houston 21
Phoenix 21
Belo Horizonte 20
Orem 20
Poplar 20
Messina 19
Abuja 18
Boston 18
Johannesburg 18
San Francisco 18
Manchester 17
Pune 17
Brasília 16
Helsinki 16
Mexico City 16
Quintano 16
Stockholm 16
Denver 15
Florence 14
Jinan 14
Aci Catena 13
Augusta 13
Bernareggio 13
Curitiba 13
Frankfurt Am Main 13
Hangzhou 13
Santa Venerina 13
Tehran 13
Verona 13
Totale 13.832
Salva come PNG Salva come JPEG
Nome #
Novel mechanisms of tumor promotion by the insulin receptor isoform a in triple-negative breast cancer cells 215
148P The impact of chemotherapy relative dose intensity on pathological complete response and event-free survival in patients with triple-negative breast cancer treated with neoadjuvant chemotherapy 208
A Custom DNA-Based NGS Panel for the Molecular Characterization of Patients With Diffuse Gliomas: Diagnostic and Therapeutic Applications 190
A Case of Non-Irradiated Balloon Cell Melanoma of the Choroid: Expanding the Morphological Spectrum of Primary Uveal Melanomas 184
Correlation between weight and Recurrence Score in a cohort of HR+ve/ HER2-ve early breast cancer patients: a retrospective analysis 182
Clinical Implications of Discordant Early Molecular Responses in CML Patients Treated with Imatinib 182
Concordance between CDKN2A homozygous deletion and MTAP immunohistochemical loss in fluoroedenite-induced pleural mesothelioma: An immunohistochemical and molecular study on a single-institution series 142
Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia 135
Activation of the IGF axis in thyroid cancer: Implications for tumorigenesis and treatment 135
Glioblastoma, IDH-Wild Type With FGFR3-TACC3 Fusion: When Morphology May Reliably Predict the Molecular Profile of a Tumor. A Case Report and Literature Review 135
DDR1 regulates thyroid cancer cell differentiation via IGF-2/IR-A autocrine signaling loop 134
High BCR-ABL/GUSISlevels at diagnosis of chronic phase CML are associated with unfavorable responses to standard-dose imatinib 133
Effect of low-dose tungsten on human thyroid stem/precursor cells and their progeny 133
Comparative proteomic analysis of insulin receptor isoform A and B signaling 131
AKT Inhibitors: New Weapons in the Fight Against Breast Cancer? 129
The Q-LAMP Method Represents a Valid and Rapid Alternative for the Detection of the BCR-ABL1 Rearrangement in Philadelphia-Positive Leukemias 128
Biomarkers and prognostic factors for malignant pleural mesothelioma 127
Knockout Serum Replacement Promotes Cell Survival by Preventing BIM from Inducing Mitochondrial Cytochrome C Release 125
Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53 125
Diagnostic utility of the immunohistochemical expression of serin and arginine rich splicing factor 1 (Srsf1) in the differential diagnosis of adult gliomas 125
Additional Genetic Alterations and Clonal Evolution of MPNs with Double Mutations on the MPL Gene: Two Case Reports 124
BCR-ABL1 doubling-times and halving-times may predict CML response to tyrosine kinase inhibitors 122
Impact of the Breakpoint Region on the Leukemogenic Potential and the TKI Responsiveness of Atypical BCR-ABL1 Transcripts 118
Anaplastic thyroid cancer in sicily: The role of environmental characteristics. 116
An Optimized Workflow to Evaluate Estrogen Receptor Gene Mutations in Small Amounts of Cell-Free DNA 116
The prognostic and predictive value of ESR1 fusion gene transcripts in primary breast cancer 113
Diagnostic methods and therapeutic options of uveal melanoma with emphasis on MR imaging—Part I: MR imaging with pathologic correlation and technical considerations 112
Molecular Alterations in Thyroid Cancer: From Bench to Clinical Practice 112
A population-based study of chronic myeloid leukemia patients treated with imatinib in first line 111
BCR-ABL tyrosine kinase activity modulates the phosphorylation and the localization of Interferon Regulatory Factor 5 (IRF-5)in Chronic Myeloid Leukemia cells 110
BCR-ABL Tyrosine Kinase Activity Modulates the Phosphorylation, Localization and Function of Interferon Regulatory Factor 5 (irf-5) in Chronic Myeloid Leukemia (CML) Cells 110
Discoidin domain receptor 1 modulates insulin receptor signaling and biological responses in breast cancer cells 110
BCR-ABL TYROSINE KINASE ACTIVITY MODULATES THE PHOSPHORYLATION, LOCALIZATION AND FUNCTION OF INTERFERON REGULATORY FACTOR 5 (IRF-5) IN CHRONIC MYELOID LEUKEMIA CELLS 109
AN INSERTION IN THE BCR-ABL KINASE DOMAIN CONTRIBUTES TO IMATINIB MESYLATE RESISTANCE 108
DeltaNp73alpha inhibits PTEN expression in thyroid cancer cells 107
BCR-ABL residues interacting with ponatinib are critical to preserve the tumorigenic potential of the oncoprotein 106
Altered expression of c-IAP1, survivin, and Smac contributes to chemotherapy resistance in thyroid cancer cells.Cancer Res 106
Heavy metals in the volcanic environment and thyroid cancer 105
Histopathologic and mr imaging appearance of spontaneous and radiation-induced necrosis in uveal melanomas: Initial results 104
New insights in thyroid cancer and p53 family proteins 103
Insulin receptor isoforms differently regulate cell proliferation and apoptosis in the ligand‐occupied and unoccupied state 103
Increased thyroid cancer incidence in volcanic areas: A role of increased heavy metals in the environment? 103
Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery 102
Next generation sequencing in a cohort of patients with rare sarcoma histotypes: A single institution experience 102
An Optimized NGS Workflow Defines Genetically Based Prognostic Categories for Patients with Uveal Melanoma 102
Giant Paratesticular Liposarcoma: Molecular Characterization and Management Principles with a Review of the Literature 101
Orbital metastasis from thyroid cancer: a case report and review of the literature 100
Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRK1 in papillary thyroid carcinoma 100
Diagnostic methods and therapeutic options of uveal melanoma with emphasis on MR imaging—Part II: treatment indications and complications 100
Abemaciclib pharmacology and interactions in the treatment of HR+/HER2− breast cancer: a critical review 99
Suppression of survivin induced by BCR-ABL/JAK2/STAT3 pathway sensitizes imatinib-resistant CML cells to different cytotoxic drugs 99
BCR-ABL TYROSINE KINASE ACTIVITY MODULATES THE PHOSPHORYLATION, LOCALIZATION AND BIOLOGICAL FUNCTION OF INTERFERON REGULATORY FACTOR 5 IN CHRONIC MYELOID LEUKEMIA CELLS 99
ENDOMETRIAL STROMAL TUMOR (SARCOMA) WITH LIMITED MIOMETRIAL INFILTRATION: A RARE CASE WITH PELVI-PERITONEAL METASTASES 98
Mechanistic Translation of Melanoma Genetic Landscape in Enriched Pathways and Oncogenic Protein-Protein Interactions 98
Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP 97
Long-Term Molecular Remission Achieved by Antibody Anti-CD22 and Ponatinib in a Patient Affected by Ph'+ Acute Lymphoblastic Leukemia Relapsed after Second Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report 97
Navigating the Nexus: HIV and Breast Cancer—A Critical Review 96
Immunoexpression of p62/SQSTM1/Sequestosome-1 in human primary and recurrent IDH1/2 wild-type glioblastoma: A pilot study 96
Concentration of Metals and Trace Elements in the Normal Human and Rat Thyroid: Comparison with Muscle and Adipose Tissue and Volcanic Versus Control Areas 96
BCR-Abl tyrosine kinase activity modulates the expression of Interferon Regulatory Factor-5 in CML cells 95
Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients 95
BRIT1/MCPH1 expression in chronic myeloid leukemia and its regulation of the G2/M checkpoint. 95
Potential Therapeutic Targets for Luminal Androgen Receptor Breast Cancer: What We Know so Far 94
c-IAP1, Survivin and Smac contribute to chemotherapy resistance in undifferentiated thyroid cancer cells 94
BCR-ABL tyrosine kinase activity modulates survivin expression via PI3K/AKT 94
Vg9Vd2 T Lymphocytes Efficiently Recognize and Kill Zoledronate-Sensitized, Imatinib-Sensitive, and Imatinib-Resistant Chronic Myelogenous Leukemia Cells 93
Combined inhibition of bcl2 and bcr-abl1 exercises anti-leukemia activity but does not eradicate the primitive leukemic cells 93
Heavy Metals in the Environment and Thyroid Cancer 92
Computational and Experimental Characterization of Two Nuclear Localization Signals and a Nuclear Export Signal that modulate BCR intracellular localization 92
BRIT1/MCPH1 expression in chronic myeloid leukemia and its regulation of the G2/M checkpoint 92
Cerebellar liponeurocytoma: clinical, histopathological and molecular features of a series of three cases, including one recurrent tumor 92
Unsuccessful dasatinib therapy in a refractory patient with chronic lymphocytic leukemia 90
Early occurrence of a thyroid carcinoma in a patient who developed Graves’ disease after treatment for Hodgkin’s disease 90
Concomitant and feasible treatment with dasatinib and the anti-EGFR antibody cetuximab plus radiotherapy in a CML patient with multiple squamous neoplasias 90
Molecular Analysis of Luminal Androgen Receptor Reveals Activated Pathways and Potential Therapeutic Targets in Breast Cancer 89
Uncommon long-term survival in a patient with chronic myeloid leukemia 89
Prognostic and Therapeutic Roles of the Insulin Growth Factor System in Glioblastoma 89
Differences among young adults, adults and elderly chronic myeloid leukemia patients 89
Biological effects of insulin and its analogs on cancer cells with different insulin family receptor expression 89
A retrospective, real-life analysis of metronomic oral single-agent cyclophosphamide for the treatment of platinum-pretreated advanced ovarian carcinoma in Italy 88
p73 tumor-suppressor activity is impaired in human thyroid cancer 88
A new kid on the block: Sacituzumab govitecan for the treatment of breast cancer and other solid tumors 88
Mesenchymal Stem Cells (MSC) Regulate Activation of Granulocyte-Like Myeloid Derived Suppressor Cells (G-MDSC) in Chronic Myeloid Leukemia Patients 87
The optimal timing between neoadjuvant therapy and surgery of breast cancer: a brief systematic review of the literature 86
BCR-ABL tyrosine kinase activity modulates Survivin expression in CML cells 86
Late Breaking Abstract - Comparison of VATS debulking surgery and HITHOC vs VATS talc pleurodesis alone in malignant pleural mesothelioma: a pilot study 86
Hypoxia Induces Imatinib Resistance in CML Cell Lines 85
Exclusion of c-Abl from the Nucleus Restrains the p73 Tumor Suppression Function 85
BCR-ABLIS Expression at Diagnosis and After 3 or 6 Months of Treatment Predicts CML Response to IMATINIB Therapy 85
Detection of an activating mutation of the thyrotropin receptor in a case of an autonomously hyperfunctioning thyroid insular carcinoma 85
Prospective Validation of the Italian Alliance Against Cancer Lung Panel in Patients With Advanced Non-Small-Cell Lung Cancer 84
RET/NTRK1 rearrangements in thyroid gland tumors of the papillary carcinoma family: correlation with clinicopathological features 84
Mr imaging–pathologic correlation of uveal melanomas undergoing secondary enucleation after proton beam radiotherapy 84
Several site-specific cancers are increased in the volcanic area in Sicily 83
The Consistency and Quality of ChatGPT Responses Compared to Clinical Guidelines for Ovarian Cancer: A Delphi Approach 82
The PU.1 transcription factor induces cyclin D2 expression in U937 cells 82
Prospective assessment of NGS-detectable mutations in CML patients with non-optimal response: the NEXT-in-CML study 82
Influence of complex variant chromosomal translocations in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors 81
Increased phospho-mTOR expression in megakaryocytic cells derived from CD34+ progenitors of essential thrombocythaemia and myelofibrosis patients 81
IRF5 is a target of BCR-ABL kinase activity and reduces CML cell proliferation. 81
Totale 10.717
Salva come PNG Salva come JPEG
Categoria #
all - tutte 73.391
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.391
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021991 0 0 0 0 304 36 136 6 233 4 185 87
2021/20221.496 155 202 22 20 229 37 223 49 136 28 56 339
2022/20232.775 228 144 58 296 208 462 32 540 633 20 94 60
2023/20241.443 108 220 52 78 76 257 34 86 10 67 268 187
2024/20255.951 159 869 311 258 1.148 686 255 185 364 460 780 476
2025/20265.899 736 720 2.065 771 1.607 0 0 0 0 0 0 0
Totale 20.250